Cite
HARVARD Citation
Bekker, A. et al. (2022). Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study. Journal of acquired immune deficiency syndromes. pp. 324-331. [Online].